Tesamorelin

Tesamorelin targets one of the hardest places to change - visceral fat - by stimulating your body’s own growth-hormone pathway. Often selected for assistance in body recomposition.

3mg/mL Injection (5ml)

Tesamorelin is a growth hormone-releasing hormone analogue that stimulates the pituitary gland to increase endogenous growth hormone secretion and downstream IGF-1 signaling.

Unlike many peptides marketed for body composition, Tesamorelin has meaningful human clinical research behind it. In studied populations, it has demonstrated the ability to reduce visceral adipose tissue—the metabolically active fat stored around internal organs.

Its effects are linked to changes in growth-hormone signaling, lipid metabolism, and body composition rather than simple appetite suppression.

Tesamorelin is therefore particularly relevant to research involving visceral fat, metabolic health, body composition, and the physiological changes associated with declining growth-hormone activity.